S R Findlay|L M Lichtenstein - JoVE Visualize

Showing results (111-120 of 401) with videos related to

Pageof 41

Sort By:

International Archives of Allergy and Immunology|May 1, 1995

The interaction of cytokines with human basophils and mast cellsJ T Schroeder, A Kagey-Sobotka, D W MacGlashan, et al.

The Journal of Allergy and Clinical Immunology|January 1, 1997

Differential efficacy of lymphocyte- and monocyte-selective pretreatment with a type 4 phosphodiesterase inhibitor on antigen-driven proliferation and cytokine gene expressionD M Essayan, S K Huang, A Kagey-Sobotka, et al.

Blood|February 1, 1992

Immunophenotyping and functional analysis of purified human uterine mast cellsC B Guo, A Kagey-Sobotka, L M Lichtenstein, et al.

Laboratory Investigation; a Journal of Technical Methods and Pathology|June 1, 1986

Human mast cells use conservation and condensation mechanisms during recovery from degranulation. In vitro studies with mast cells purified from human lungsA M Dvorak, R P Schleimer, E S Schulman, et al.

JAMA|March 17, 1975

Immunotherapy in bee-sting anaphylaxis. Use of honeybee venomW W Busse, C E Reed, L M Lichtenstein, et al.

Journal of Immunological Methods|February 13, 1995

IgA, IgG and IgM quantification in bronchoalveolar lavage fluids from allergic rhinitics, allergic asthmatics, and normal subjects by monoclonal antibody-based immunoenzymetric assaysR S Peebles, M C Liu, L M Lichtenstein, et al.

Biochemical Pharmacology|April 4, 1997

Regulation of interleukin-13 by type 4 cyclic nucleotide phosphodiesterase (PDE) inhibitors in allergen-specific human T lymphocyte clonesD M Essayan, A Kagey-Sobotka, L M Lichtenstein, et al.

Clinical Allergy|January 1, 1988

IgE and IgG antibody response to purified bee-venom antigens and peptides in four patients who had adverse reactions to immunotherapyD M Kemeny, A Kagey-Sobotka, L M Lichtenstein, et al.

Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1986

Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroidsR P Schleimer, D A Davidson, L M Lichtenstein, et al.

The Journal of Allergy and Clinical Immunology|May 1, 1989

Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reactionE N Charlesworth, A Kagey-Sobotka, P S Norman, et al.

Pageof 41

Showing results (111-120 of 401) with videos related to

Sort By:

Pageof 41

International Archives of Allergy and Immunology|May 1, 1995

The interaction of cytokines with human basophils and mast cellsJ T Schroeder, A Kagey-Sobotka, D W MacGlashan, et al.

The Journal of Allergy and Clinical Immunology|January 1, 1997

Differential efficacy of lymphocyte- and monocyte-selective pretreatment with a type 4 phosphodiesterase inhibitor on antigen-driven proliferation and cytokine gene expressionD M Essayan, S K Huang, A Kagey-Sobotka, et al.

Blood|February 1, 1992

Immunophenotyping and functional analysis of purified human uterine mast cellsC B Guo, A Kagey-Sobotka, L M Lichtenstein, et al.

Laboratory Investigation; a Journal of Technical Methods and Pathology|June 1, 1986

Human mast cells use conservation and condensation mechanisms during recovery from degranulation. In vitro studies with mast cells purified from human lungsA M Dvorak, R P Schleimer, E S Schulman, et al.

JAMA|March 17, 1975

Immunotherapy in bee-sting anaphylaxis. Use of honeybee venomW W Busse, C E Reed, L M Lichtenstein, et al.

Journal of Immunological Methods|February 13, 1995

IgA, IgG and IgM quantification in bronchoalveolar lavage fluids from allergic rhinitics, allergic asthmatics, and normal subjects by monoclonal antibody-based immunoenzymetric assaysR S Peebles, M C Liu, L M Lichtenstein, et al.

Biochemical Pharmacology|April 4, 1997

Regulation of interleukin-13 by type 4 cyclic nucleotide phosphodiesterase (PDE) inhibitors in allergen-specific human T lymphocyte clonesD M Essayan, A Kagey-Sobotka, L M Lichtenstein, et al.

Clinical Allergy|January 1, 1988

IgE and IgG antibody response to purified bee-venom antigens and peptides in four patients who had adverse reactions to immunotherapyD M Kemeny, A Kagey-Sobotka, L M Lichtenstein, et al.

Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1986

Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroidsR P Schleimer, D A Davidson, L M Lichtenstein, et al.

The Journal of Allergy and Clinical Immunology|May 1, 1989

Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reactionE N Charlesworth, A Kagey-Sobotka, P S Norman, et al.

Pageof 41